VectivBio Holding AG VECT

Market cap
$545.5M
P/E
0.0×
Dec '22 Jun '22 Dec '21 Jun '21 Older periods
ROE
(147.18%) 0.00% 0.00% —

+2 more TTM periods

ROA
(111.86%) 0.00% 0.00% —
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(89.51%) (133.16%) (157.55%) 0.00%
Average Days of Receivables
0.00 0.00 0.00 0.00
Free Cash Flow per Share
0.00 0.00 0.00 0.00
Free Cash Flow
(176.61) — — —
Capital Expenditures
(0.24) — — —
Piotroski F-Score
1.00 0.00 0.00 0.00
Other line items
Cash ROIC
(39.62%) 0.00% 0.00% 0.00%
Accounts Receivable Turnover
0.00 — — —
Average Days of Payables
0.00 0.00 0.00 —
Tax Rate
0.00 0.00 0.00 —
Research and Development Expense of Revenue
0.00% 0.00% 0.00% —
Selling, General and Administrative Expense of Revenue
— 0.00% 0.00% —
Operating CF/Net income
0.98 0.00 0.00 —
Depreciation/Fixed assets
2.05 0.00 0.00 0.00
Capex/Depreciation
(0.26) — — —
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
0.00 0.00 0.00 0.00
Capex per Share
0.00 0.00 0.00 0.00
Capex to Sales
0.00 — — —
Net Profit Margin
0.00% 0.00% 0.00% —

Fold the line items

Columns are period end dates